Effects of Angiotensin Receptor-Neprilysin Inhibitors on Lung Cancer Patients with Hypertension Receiving Immune Checkpoint Inhibitor Therapy

• by Conghui Shang, Hao Wang, Jindong Chen, Shuhui Cao, Yingjia Sun, Ziyi Sheng, Tianqing Chu, Liang Zhao

• December 27, 2025

Frailty may not limit semaglutide benefits

Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.

• by Andrea Surnit

• October 16, 2026

• 5 min

An Indigenous Food Is Medicine Intervention: The MUTTON-HF Randomized Clinical Trial

• by Lauren A. Eberly, Carmen George, Sharon Sandman, Denee Bex, Karianne Jones, Asia Yazzie, Leah Gray, Larissa Morgan, Ada Tennison, Conor Williams, Matt Chandra, Rebecca Wickre, Bennett Wickre, Mackenzie Bolas, Remi Welbel, Delaney Ignace, Benjamin Feliciano, Stacy Hammer, DezBaa Damon-Mallette, Erica Lindsey, Paula Mora, Aijun Ye, Maricruz Merino, Enrique F. Schisterman, Sonya S. Shin

• September 1, 2026

Accelerometer-Based Activity Sensing by an Insertable Cardiac Monitor In Ambulatory Patients: A Subanalysis of LUX-Dx TRENDS (LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study)

• by ANDREW J. SAUER, E. MATTHEW QUIN, KARAN BHALLA, SASHI ADIGOPULA, BIN MI, EMILY THOMPSON, DEEPA MAHAJAN, MING DUANMU, CRAIG M. STOLEN, MOLLY E. KUPFER, ALYSIA ROSNER, SELÇUK ADABAG, SCOTT D. SOLOMON, ELAINE Y. WAN

• October 11, 2026